Molecule of the month. Sugammadex sodium.
D000732:Androstanols / Q000037:antagonists & inhibitors; D017326:Clinical Trials, Phase III as Topic; D006801:Humans; D015394:Molecular Structure; D009465:Neuromuscular Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D009466:Neuromuscular Blocking Agents / Q000037:antagonists & inhibitors; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*
D000732:Androstanols; D009465:Neuromuscular Agents; D009466:Neuromuscular Blocking Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D000077123:Rocuronium